Pacific Edge (Pacific Edge) Forward PE Ratio : 0.00 (As of Jun. 16, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Forward PE Ratio?

Pacific Edge's Forward PE Ratio for today is 0.00.

Pacific Edge's PE Ratio without NRI for today is 0.00.

Pacific Edge's PE Ratio for today is 0.00.

Pacific Edge Forward PE Ratio Historical Data

The historical data trend for Pacific Edge's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Forward PE Ratio Chart

Pacific Edge Annual Data

Trend

2016-12

2017-12

2018-01

2020-12

2021-01

Forward PE Ratio

86.96

14.84

21.69

47.39

48.31

Pacific Edge Semi-Annual Data
	2016-12	2017-12	2020-12
Forward PE Ratio	86.96	14.84	47.39

Competitive Comparison of Pacific Edge's Forward PE Ratio

For the Diagnostics & Research subindustry, Pacific Edge's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pacific Edge's Forward PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Forward PE Ratio falls into.

Pacific Edge Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Pacific Edge (OTCPK:PFGTF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Pacific Edge Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Edge (Pacific Edge) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

PEB:New Zealand PEB:Australia

Address

87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016

Website

https://www.pacificedgedx.com

Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.